SB2035, the Protect IVF Act, sets a federal baseline that individuals can receive fertility treatment, health care providers can offer it, insurers can cover it, and manufacturers can market related drugs and devices when aligned with widely accepted medical standards. The bill anchors these rights in federal law and requires enforcement through the Attorney General and a private right of action.
It aims to reduce state-by-state variation that can impede access to fertility care and to standardize care around established medical guidelines.
At a Glance
What It Does
The Act creates statutory rights for individuals, providers, insurers, and manufacturers to engage with fertility treatment in accordance with widely accepted medical standards, and it authorizes enforcement when state laws or regulations obstruct those rights.
Who It Affects
Patients seeking fertility care, fertility clinics and providers, health insurance issuers that cover fertility services, manufacturers of fertility drugs and devices, and State regulators.
Why It Matters
By establishing a federal baseline and a private/public enforcement framework, the Act seeks consistent access to fertility treatments across states and reduces legal risk and regulatory fragmentation for providers and payers.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The Protect IVF Act would create nationwide, federally enforceable rights related to fertility treatment. Individuals would have a right to receive fertility care from providers who follow widely accepted medical standards.
Providers would have the right to offer such treatments, subject to those standards, and could contract with patients for their services. Health insurance issuers would gain the right to cover fertility treatment as part of their plans, and manufacturers would be protected to market drugs and devices used in fertility care.
The act explicitly defines what counts as fertility treatment and who is covered, including storage and handling of reproductive material, genetic testing, and assisted reproductive technologies.
The bill relies on guidelines from the American Society for Reproductive Medicine as the benchmark for care. It also creates strong enforcement mechanisms: the Attorney General can sue to strike down state restrictions that block these rights, and individuals or entities harmed by such restrictions can sue for relief.
Importantly, the act preempts conflicting state laws but preserves certain federal and privacy protections, and it preserves the Federal Food, Drug, and Cosmetic Act and HIPAA while aligning them with fertility treatment rights. Telemedicine and residency considerations are addressed in the broader construction of rights to ensure access remains feasible across jurisdictions.
The Five Things You Need to Know
The bill defines fertility treatment to include preservation, insemination, ART, genetic testing, medications, and gamete donation.
A federal right is created for individuals, providers, insurers, and manufacturers to engage in fertility treatment under widely accepted medical standards.
The Act preempts conflicting state laws, establishing federal supremacy over restrictive or burdensome regulations.
Enforcement includes the Attorney General and a private right of action with awards of costs and attorney’s fees to prevailing plaintiffs.
Standards of care are anchored to guidelines from the American Society for Reproductive Medicine, with preservation of federal health authorities and HIPAA protections.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short Title
This section designates the act as the Protect IVF Act, setting the framing for what follows in federal law.
Purposes
The purposes articulate four aims: to allow patients to seek fertility care consistent with medical standards, to enable providers to offer those services, to empower patients to make informed decisions about reproductive options, and to align federal policy with evidence-based care.
Definitions
Key terms are defined: fertility treatment (including ART, preservation, insemination, medications, and related services designated by HHS), health care provider, health insurance issuer, and manufacturer; standards of care are tied to widely accepted guidelines (ASRM).
Fertility Treatment Rights
This is the core rights section. Individuals may receive and continue fertility care, manage reproductive materials, and contract for services with providers. Providers may offer fertility treatments and related testing, storage, and material disposition. Insurers may cover treatment, and manufacturers may market drugs and devices used in fertility care, all consistent with the defined medical standards.
Applicability and Preemption
This section states that the Act supersedes conflicting state laws and prohibits states from enacting provisions that interfere with the rights created by the Act. It carves out limited exceptions for certain disputes and compatibility with other federal laws, while preserving HIPAA and other public health authorities. It also provides for defense in enforcement actions and lays out jurisdictional provisions.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Patients seeking fertility treatment gain consistent access across states and protection of their treatment decisions.
- Fertility clinics and other providers can operate with a clearer federal standard and reduced risk of conflicting state restrictions.
- Health insurance issuers have a federal framework for coverage that supports consistency across markets.
- Manufacturers of fertility drugs and devices can market and distribute within a stable federal framework.
- State and federal health regulators gain a baseline to measure compliance against a uniform standard.
Who Bears the Cost
- States may face adjustments to align or repeal conflicting regulations due to preemption, with associated administrative and oversight costs.
- Health care providers and clinics may incur compliance costs to ensure services align with the standardized guidelines and reporting requirements.
- Health insurers may incur administrative costs to implement coverage consistent with the federal standard and handle disputes under the new enforcement regime.
- Manufacturers may face compliance obligations to ensure marketing and distribution align with the standard of care and regulatory requirements.
- Litigation costs may rise for entities challenging or defending rights under the Act, though prevailing plaintiffs can recover costs and attorney’s fees.
Key Issues
The Core Tension
The central dilemma is whether a federal rights framework can both protect patient access to fertility care across all states and accommodate legitimate state variations in health delivery systems without stifling local clinical judgment or imposing rigid, nationwide practices.
The Act creates a federal baseline for fertility treatment rights and preempts conflicting state laws, but it also preserves existing federal health authorities and privacy protections. This balance seeks to prevent a patchwork of state regulations while avoiding overreach into unrelated health policy areas.
Practical tensions include ensuring that the federal standard remains workable across diverse state health systems and that enforcement actions do not unduly burden providers or states in implementing the law. The reliance on ASRM guidelines anchors care to a professional standard, but the guidelines themselves evolve, which could create dynamic compliance considerations for providers and insurers.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.